Cerity Partners’s Nu Skin NUS Stock Holding History

Cerity Partners’s Portfolio NUS Stock Details NUS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$55.7K	Sell	10,553 -3,545	-25%	-$22.7K	﹤0.01%	3290
2026 Q1	$103K	Buy	+14,098	New	+$128K	﹤0.01%	3023
2025 Q2	–	Sell	-37,985	Closed	-$276K	–	2723
2025 Q1	$276K	Buy	37,985 +17,824	+88%	+$130K	﹤0.01%	2063
2024 Q4	$141K	Buy	+20,161	New	+$139K	﹤0.01%	2294
2024 Q3	–	Sell	-17,199	Closed	-$181K	–	2581
2024 Q2	$181K	Buy	+17,199	New	+$218K	﹤0.01%	2044
2024 Q1	–	Sell	-46,112	Closed	-$896K	–	2333
2023 Q4	$896K	Sell	46,112 -4,261	-8%	-$78.6K	﹤0.01%	1026
2023 Q3	$1.07M	Buy	50,373 +3,783	+8%	+$98.3K	0.01%	737
2023 Q2	$1.55M	Buy	+46,590	New	+$1.72M	0.01%	792

Other funds holding NUS

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

American Century Companies Kansas City, Missouri $226B AUM 44.75% 1-Year Est. Return

CAS

Coppell Advisory Solutions Coppell, Texas $1.21B AUM 20.39% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Acadian Asset Management Boston, Massachusetts $84.2B AUM 55.88% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

PGCM

Prescott Group Capital Management Tulsa, Oklahoma $1.16B AUM 53.61% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return

Charles Schwab San Francisco, California $751B AUM 38.74% 1-Year Est. Return

Cerity Partners's NUS Position: Q2 2026 in Review

Cerity Partners reduced its Nu Skin (NUS) stake by 25% in Q2 2026, selling an estimated $22.7K and leaving 10,553 shares worth $55.7K. The position accounts for ﹤0.01% of the portfolio, ranked #3290.

Cerity Partners first reported a position in NUS in Q2 2023 and has held it in 8 quarters since. The position peaked at $1.55M in Q2 2023. 162 funds tracked by Wall St. Rank hold NUS as of Q2 2026.

Cerity Partners held 10,553 shares of Nu Skin worth $55.7K as of Q2 2026.
Cerity Partners sold 3,545 Nu Skin shares in Q2 2026, an estimated $22.7K.
Nu Skin made up ﹤0.01% of Cerity Partners's portfolio in Q2 2026, its #3290 holding.
Cerity Partners first reported a position in Nu Skin in Q2 2023 and has held it in 8 quarters since.
Cerity Partners's Nu Skin position peaked at $1.55M in Q2 2023.
162 funds tracked by Wall St. Rank held Nu Skin as of Q2 2026.

Based on Cerity Partners's 13F filing for Q2 2026, filed 14 Aug 2026.